col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


18 Ergebisse       Seite 1

 [1] 
Oxford University Press: Oxford Open Immunology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Mrz―07 Post-acute sequelae of SARS-CoV-2 infection in health care workers from South Africa Sthembile Mbotwe-Sibanda, Gaurav Kwatra, Shabir A Madhi, Marta C Nunes
2 [GO] 2023―Mrz―08 Autoimmunity in Long Covid and POTS Fatema-Zahra El-Rhermoul, Artur Fedorowski, Philip Eardley, Patricia Taraborrelli, Dimitrios Panagopoulos, Richard Sutton, et al. (+2)
3 [GO] 2023―Jan―19 Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2 Kriti Negi, Meetu Agarwal, Isha Pahuja, Bhavya Bhardwaj, Mansi Rawat, Ashima Bhaskar, Ved Prakash Dwivedi
4 [GO] 2023―Jan―03 Endogenous antibody responses in REGN-COV2 treated SARS-CoV-2 infected individuals Ashwini Kurshan, Luke Snell, Lucie Prior, Jerry C H Tam, Carl Graham, Rajeni Thangarajah, et al. (+3)
5 [GO] 2022―Sep―27 Long Covid brain fog: a neuroinflammation phenomenon? Emma Kavanagh
6 [GO] 2022―Sep―15 Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity Simon Haunhorst, Wilhelm Bloch, Heiko Wagner, Claudia Ellert, Karsten Krüger, Daniel C Vilser, et al. (+5)
7 [GO] 2022―Aug―17 SARS-CoV-2 immunity and vaccine strategies in people with HIV Claire Mullender, Kelly A S da Costa, Aljawharah Alrubayyi, Sarah L Pett, Dimitra Peppa
8 [GO] 2022―Jun―20 The past, current and future epidemiological dynamic of SARS-CoV-2 François Balloux, Cedric Tan, Leo Swadling, Damien Richard, Charlotte Jenner, Mala Maini, Lucy van Dorp
9 [GO] 2021―Mai―21 Overview of approved and upcoming vaccines for SARS-CoV-2: a living review Jennifer Alderson, Vicky Batchelor, Miriam O’Hanlon, Liliana Cifuentes, Felix Clemens Richter, Jakub Kopycinski
10 [GO] 2021―Feb―23 The T cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role Antonio Bertoletti, Anthony T Tan, Nina Le Bert
11 [GO] 2021―Jan―28 The Role and Uses of Antibodies in COVID-19 Infections: A Living Review D Oliver Scourfield, Sophie G Reed, Max Quastel, Jennifer Alderson, Valentina M T Bart, Alicia Teijeira Crespo, et al. (+4)
12 [GO] 2021―Jan―26 Mucosal immune responses in COVID-19 Claire F Pearson, Rebecca Jeffery, Emily E Thornton
13 [GO] 2021―Jan―22 Impact of obesity on host defences: Implications for SARS-CoV-2 infection Felix Clemens Richter, Aljawharah Alrubayyi, Alicia Teijeira Crespo, Sarah Hulin-Curtis
14 [GO] 2020―Dez―29 T cell phenotypes in COVID-19 Stephanie J Hanna, Amy S Codd, Ester Gea-Mallorqui, D Oliver Scourfield, Felix C Richter, Kristin Ladell, et al. (+11)
15 [GO] 2020―Dez―09 Innate immunology in COVID-19 - A LIVING REVIEW PART I: Viral entry, sensing and evasion Clarissa Coveney, Michel Tellier, Fangfang Lu, Shayda Maleki Toyserkani, Ruth Jones, Valentina M T Bart, et al. (+8)
16 [GO] 2020―Dez―09 Innate immunology in COVID-19 - A LIVING REVIEW PART II: Dysregulated inflammation drives immunopathology Patrícia R S Rodrigues, Aljawharah Alrubayyi, Ellie Pring, Valentina M T Bart, Ruth Jones, Clarissa Coveney, et al. (+7)
17 [GO] 2020―Jul―09 Adaptive immunity to SARS-CoV-2 Daniel M Altmann
18 [GO] 2020―Jun―17 Cholesterol-modifying drugs in COVID-19 Nathalie M Schmidt, Peter A C Wing, Jane A McKeating, Mala K Maini
 [1] 

18 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec